SSY Fundamental Analysis - SUNLINK HEALTH SYSTEMS INC

Name: SUNLINK HEALTH SYSTEMS INC (SSY) Stock
Brand: SUNLINK HEALTH SYSTEMS INC
Rating: 3.5 (3 reviews)

Fundamental Rating

We assign a fundamental rating of 4 out of 10 to SSY. SSY was compared to 101 industry peers in the Health Care Providers & Services industry. No worries on liquidiy or solvency for SSY as it has an excellent financial health rating, but there are worries on the profitability. SSY is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year SSY was profitable.

In the past year SSY has reported a negative cash flow from operations.

SSY had negative earnings in 4 of the past 5 years.

In multiple years SSY reported negative operating cash flow during the last 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of 9.87%, SSY belongs to the top of the industry, outperforming 93.27% of the companies in the same industry.

With an excellent Return On Equity value of 12.86%, SSY belongs to the best of the industry, outperforming 80.77% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	9.87%
ROE	12.86%
ROIC	N/A

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

With a decent Profit Margin value of 5.55%, SSY is doing good in the industry, outperforming 79.81% of the companies in the same industry.

With a decent Gross Margin value of 43.05%, SSY is doing good in the industry, outperforming 70.19% of the companies in the same industry.

SSY's Gross Margin has declined in the last couple of years.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	5.55%
GM	43.05%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-10.82%

GM growth 5Y-5.67%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

SSY does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, SSY has more shares outstanding

The number of shares outstanding for SSY has been increased compared to 5 years ago.

SSY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

An Altman-Z score of 2.88 indicates that SSY is not a great score, but indicates only limited risk for bankruptcy at the moment.

The Altman-Z score of SSY (2.88) is better than 61.54% of its industry peers.

There is no outstanding debt for SSY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Altman-Z	2.88

ROIC/WACCN/A

WACC8.9%

2.3 Liquidity

A Current Ratio of 3.91 indicates that SSY has no problem at all paying its short term obligations.

With an excellent Current ratio value of 3.91, SSY belongs to the best of the industry, outperforming 88.46% of the companies in the same industry.

A Quick Ratio of 3.50 indicates that SSY has no problem at all paying its short term obligations.

Looking at the Quick ratio, with a value of 3.50, SSY belongs to the top of the industry, outperforming 88.46% of the companies in the same industry.

		Industry Rank	Sector Rank
Current Ratio	3.91
Quick Ratio	3.5

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 125.41% over the past year.

Looking at the last year, SSY shows a very negative growth in Revenue. The Revenue has decreased by -12.45% in the last year.

Measured over the past years, SSY shows a decrease in Revenue. The Revenue has been decreasing by -6.58% on average per year.

EPS 1Y (TTM)125.41%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%52.89%

Revenue 1Y (TTM)-12.45%

Revenue growth 3Y-7.28%

Revenue growth 5Y-6.58%

Sales Q2Q%-1.86%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 4.29, the valuation of SSY can be described as very cheap.

99.04% of the companies in the same industry are more expensive than SSY, based on the Price/Earnings ratio.

Compared to an average S&P500 Price/Earnings ratio of 26.10, SSY is valued rather cheaply.

		Industry Rank	Sector Rank
PE	4.29
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

SSY does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

SUNLINK HEALTH SYSTEMS INC

NYSEARCA:SSY (8/14/2025, 8:04:00 PM)

After market: 1.0701 -0.04 (-4.03%)

1.115

+0.16 (+16.15%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Providers & Services

Earnings (Last)05-14 2025-05-14

Earnings (Next)09-29 2025-09-29

Inst Owners11.33%

Inst Owner Change-1.41%

Ins Owners28.31%

Ins Owner Change-145.48%

Market Cap7.85M

Revenue(TTM)31.09M

Net Income(TTM)1.73M

Analysts0

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-Date07-31 2025-07-31 (0.1)

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	4.29
Fwd PE	N/A
P/S	0.25
P/FCF	N/A
P/OCF	N/A
P/B	0.59
P/tB	0.64
EV/EBITDA	N/A

EPS(TTM)0.26

EY23.32%

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)-0.55

FCFYN/A

OCF(TTM)-0.42

OCFYN/A

SpS4.42

BVpS1.9

TBVpS1.74

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	9.87%
ROE	12.86%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	5.55%
GM	43.05%
FCFM	N/A

ROA(3y)N/A

ROA(5y)N/A

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-10.82%

GM growth 5Y-5.67%

F-Score4

Asset Turnover1.78

Health

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	48.16%
Cap/Sales	3.03%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	3.91
Quick Ratio	3.5
Altman-Z	2.88

F-Score4

WACC8.9%

ROIC/WACCN/A

Cap/Depr(3y)133.35%

Cap/Depr(5y)134.66%

Cap/Sales(3y)5.57%

Cap/Sales(5y)5.12%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)125.41%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%52.89%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-12.45%

Revenue growth 3Y-7.28%

Revenue growth 5Y-6.58%

Sales Q2Q%-1.86%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y3.96%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-78.86%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-451.48%

OCF growth 3YN/A

OCF growth 5YN/A

SUNLINK HEALTH SYSTEMS INC / SSY FAQ

What is the ChartMill fundamental rating of SUNLINK HEALTH SYSTEMS INC (SSY) stock?

ChartMill assigns a fundamental rating of 4 / 10 to SSY.

What is the valuation status for SSY stock?

ChartMill assigns a valuation rating of 2 / 10 to SUNLINK HEALTH SYSTEMS INC (SSY). This can be considered as Overvalued.

How profitable is SUNLINK HEALTH SYSTEMS INC (SSY) stock?

SUNLINK HEALTH SYSTEMS INC (SSY) has a profitability rating of 3 / 10.

What is the financial health of SUNLINK HEALTH SYSTEMS INC (SSY) stock?

The financial health rating of SUNLINK HEALTH SYSTEMS INC (SSY) is 8 / 10.

SUNLINK HEALTH SYSTEMS INC (SSY) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

SUNLINK HEALTH SYSTEMS INC / SSY FAQ

What is the ChartMill fundamental rating of SUNLINK HEALTH SYSTEMS INC (SSY) stock?

What is the valuation status for SSY stock?

How profitable is SUNLINK HEALTH SYSTEMS INC (SSY) stock?

What is the financial health of SUNLINK HEALTH SYSTEMS INC (SSY) stock?